Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typing

25 Dec 2017

Abstract excerpt

Enterococcal infections have become one of the most challenging nosocomial problems. Tedizolid, the second oxazolidinone, is 4-fold to 8-fold more potent in vivo and in vitro than linezolid against enterococci. However, the characteristics of tedizolid related to enterococci isolates in China remain elusive. The aim of this study was to evaluate in vitro activity of tedizolid against enterococcal isolates from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Bacterial biofilms and quorum sensing
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29390078
DOI: 10.1093/femsle/fnx284

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typingPMID 29390078Read ↗

Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.Semantic proximity Read ↗

Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and EuropeSemantic proximity Read ↗

In vitro activity of tedizolid against linezolid-resistant staphylococci and enterococci.Semantic proximity Read ↗

Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.Semantic proximity Read ↗

Tedizolid for the Management of Human Infections: In Vitro CharacteristicsSemantic proximity Read ↗

Linezolid Resistance in Enterococcus faecalis Associated With Urinary Tract Infections of Patients in a Tertiary Hospitals in China: Resistance Mechanisms, Virulence, and Risk FactorsSemantic proximity Read ↗

Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China.Semantic proximity Read ↗

In Vitro Activity of Tedizolid against Mycobacterium tuberculosisSemantic proximity Read ↗

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance.Semantic proximity Read ↗

Thrombocytopenia and Tedizolid: A new ally in hematologic patients? Brief literature review and a clinical caseSemantic proximity Read ↗

New Gram-Positive Agents: the Next Generation of Oxazolidinones and LipoglycopeptidesSemantic proximity Read ↗

Identification of a novel tedizolid resistance mutation in rpoB of MRSA after in vitro serial passage.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.